Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Johnson & Johnson To Acquire Ollin Biosciences In $2.2 Bln Deal

(RTTNews) - Healthcare company Johnson & Johnson (JNJ) announced on Monday that it has agreed to acquire clinical-stage biopharmaceutical company Ollin Biosciences for $2.2 billion upfront, expanding its ophthalmology pipeline.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

JP Morgan forecasts 2% monthly inflation in Argentina in 2027

The bank expects 31% annual inflation for 2026, barely below last year's figure, and warns currency pressures could push prices La entrada JP Morgan forecasts 2% monthly inflation in Argentina in 2027…

  • J.P. Morgan forecasts 2% monthly inflation in Argentina for 2027.
  • Tensions in foreign exchange market could revise forecast upward.
  • Inflation reached 26.3% cumulative through October 2025.

More from Monday 16 November →